<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="136219">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01966380</url>
  </required_header>
  <id_info>
    <org_study_id>Leia</org_study_id>
    <nct_id>NCT01966380</nct_id>
  </id_info>
  <brief_title>Proof of Concept (Design Validation) in Patient With Hard to Heal Wounds Such as Pressure Ulcer, Diabetic Foot Ulcer and Leg Ulcer, Leia</brief_title>
  <official_title>An Open Randomised, Prospective, Crossover, Proof of Concept (Design Validation) Clinical Investigation to Caompare the Performance and Safety of Wound Dressing(Leia) Compared to and Hydroactive Surgical Dressing on Low to Highly Exuding Wounds</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Molnlycke Health Care AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Molnlycke Health Care AB</source>
  <oversight_info>
    <authority>Sweden: Regional Ethical Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this reseach study is to determine Mölnlycke Health Care´s Leia dressing
      performance properties is fulfilled and that the dressing is safe when used on wound types
      such as pressure ulcer, leg ulcer, and diabetic foot ulcer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Number of participants with Adverse events as a Measure of safety and telerability</measure>
    <time_frame>2-3 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluate the performance of the investigational device dressing, with the regards to leakage, maceration and pain at dressing changes. ( Time fram: 2-3 weeks) ( Designated as safety issue: No)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the performance of the investigational device dressing.</measure>
    <time_frame>2-3 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluate the performance of the investigational device dressing, with the regards to leakage, maceration and pain at dressing changes.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Leg Ulcer</condition>
  <condition>Diabetic Foot Ulcer</condition>
  <condition>Pressure Ulcer</condition>
  <arm_group>
    <arm_group_label>Device,  dressing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: Device, Leia dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dressing , device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention: Device: Hydroactive surgical dressing</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Leia</intervention_name>
    <arm_group_label>Device,  dressing</arm_group_label>
    <arm_group_label>Dressing , device</arm_group_label>
    <other_name>Leia consist of conducting and absorbing part.</other_name>
    <other_name>Device: Hydroactive surgical dressing</other_name>
    <other_name>It is a synergetic combination of a hydroactive surgical dressing</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Low to highly exuding chronic wound(wound history &gt; 2 months) such as Leg Ulcer,
             Pressure Ulcer Category III to IV or Diabetic Foot Ulcer

          -  Male of female, 18 years and above

          -  Signed Informed Consent Form

        Exclusion Criteria:

          -  Pregnancy or lactation

          -  Wound size not suitable for the wound dressing size

          -  Known allergy/hypersensitivity to any of the components in the dressing
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sahlgrenska clinical trial center</name>
      <address>
        <city>Göteborg</city>
        <zip>41346</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan Curiac, MD</last_name>
      <phone>+46313421000</phone>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>October 16, 2013</lastchanged_date>
  <firstreceived_date>October 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pressure Ulcer</mesh_term>
    <mesh_term>Leg Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
